Pharmacogenetics – Tailoring Your Product to Fit the Genes

John received anti-malarial therapy and developed severe hemolytic anemia.  He was diagnosed as having G6PD deficiency. Sally was started on warfarin and there was a problem in achieving the desired therapeutic response.  She was diagnosed as having the CYP2C9 *2 variant. In John’s case a genetic variant resulted in a potentially life-threatening adverse event while in Sally’s […]